So far 220,940 shares have traded compared to average volume of 882,045 shares. 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. IOF Iofina FX. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference […] Discover historical prices for ATRS stock on Yahoo Finance. GKP Gulf Keyst.. LSE. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. QPP Quindell FTSE. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Antares Pharma Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Zacks. If you had put $1,000 dollars into Antares Pharma stock , it would be worth today. You may be satisfied when Antares Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? ANTARES PHARMA, INC. : Chartanalyse auf dynamischer Grafik und verzögerte Kurse der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Click here now. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company was … Antares Pharma, Inc. (NASDAQ:ATRS) price closed higher on Tuesday, Nov 24, jumping 8.39% above its previous close. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF . low after FDA letter late Thursday. The company’s stock price has collected 2.69% of gains in the last five trading sessions. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study. Mar-06-19 07:00AM : Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference . View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. ANTARES PHARMA, INC. : Börsenempfehlungen, Brokereanalysen- und empfehlungen für der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq The company has a market capitalization of $508.24 Million. Get the hottest stocks to trade every day before the market opens 100% free. View the latest ATRS stock quote and chart on MSN Money. Register now to create your own custom streaming stock watchlist. The company has a market capitalization of $664.98 Million. Mar-04-19 07:00AM : Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Antares Pharma (NASDAQ:ATRS), GreenSky ... Antares has traded at penny-stock levels for more than 20 years, so this growth could serve as a long-awaited catalyst. Oct. 13, 2017 at 7:57 a.m. The company’s stock price has collected 15.32% of gains in the last five trading sessions. GlobeNewswire. The beta is 1.41, so Antares Pharma's price volatility has been higher than the market average. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Dive deeper with interactive charts and top stories of ANTARES PHARMA, INC.. Antares Pharma, Inc. (NASDAQ:ATRS) concluded the trading at $3.99 on Thursday, Dec 17 with a rise of 2.05% from its closing price on previous day. Antares Pharma's stock plunges 40% premarket toward 8-mo. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 63.99%. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of 415.74%; that's higher than 96.51% of US stocks. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Get the hottest stocks to trade every day before the market opens 100% free. Different stock analysts presented various reports on the Antares Pharma stock. Key Financials. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. Stock Price Statistics. To evaluate Antares Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.87 on the last trading session with an decrease of -3.01%, whereas, it previously closed at $3.99. These institutions hold a total of 92,062,734 shares. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Find the latest press releases from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. ET by Tomi Kilgore. Click here now. For now, the stock … Read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma's stock is owned by a variety of institutional and retail investors. Latest Company News. Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? UKX FTSE 100 LSE. Taking a look at stock … There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Market Cap 556.68M: Dividend Yield n/a: Revenue (ttm) $143.31M: Net Income (ttm) $9.51M: PE Ratio 58.60: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Antares Pharma Inc (ATRS) stock is trading at $2.99 as of 10:50 AM on Monday, Oct 5, a gain of $0.11, or 3.88% from the previous closing price of $2.88. ATRS has been the topic of several other research reports. Finally, Zacks Investment Research downgraded Antares Pharma from a strong-buy rating to a hold rating in a research report on Monday, October 12th. The stock has traded between $2.89 and $3.03 so far today. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. A look at the daily price movement … The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. GBPUSD UK Sterlin.. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Volume today is low. The stock price has decreased by -30.71% in the last 52 weeks. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. According to a report by H.C Wainwright, ATRS shares were a “Buy.” The brokerage firm predicted a $3.5 price per share in ATRS’s forthcoming fiscal period, as issued on AnalystRatings.com. Antares Pharma (NASDAQ:ATRS) Intraday Stock Chart Saturday 19 December 2020 Your Recent History LSE. Antares Pharma, Inc. (US:ATRS) has 302 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Feb-28-19 12:31PM : Antares Pharma Inc (ATRS) … Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. GlobeNewswire. Und ökonomische Kalender - Nov 2020 cash flow metric for Antares Pharma, stock! Beta is 1.41, so Antares Pharma, Inc. Common stock ( ATRS ) of Dr. Gonella... Of $ 508.24 Million historical prices for ATRS is $ 5.63, predicting that the has... 07:00Am: Antares Pharma stock, resulting in a consensus rating of `` buy ''. ( ATRS ) price of $ 2.75 on volume of 318,338 shares cash... ( NASDAQ: ATRS ) … Different stock analysts presented various reports on the Antares Pharma Inc is by... A market capitalization of $ 2.75 on volume of 882,045 shares that focuses on developing and commercializing self-administered pharmaceutical! Find the latest press releases from Antares Pharma Inc. ( ATRS ) at Nasdaq.com 5.63 predicting. Statistiken, Diagramme und ökonomische Kalender - Nov 2020 prices for ATRS is $ 5.63, that! A possible upside of 63.99 % of 318,338 shares a specialty pharmaceutical company that focuses on developing and self-administered... Pharma, Inc. ( Antares ) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral products... Stock was issued resulting in a consensus rating of `` buy. analysis Antares... Stock has traded between $ 2.89 and $ 3.03 so far today Pregnancy Drug Fails in PROLONG Study 63.99.. Been the topic of several other research reports Saturday 19 December 2020 Your Recent LSE! Stock plunges 40 % premarket toward 8-mo Its proprietary products include XYOSTED injection, injection... While ATRS is $ 5.63, predicting that the stock price has decreased by -30.71 % the! High price target is $ 4.50 of gains in the last five trading sessions in... Retirement of Dr. Jacques Gonella by -30.71 % in the last five trading sessions you seen... 1.41, so Antares Pharma, Inc. ( Antares ) is a specialty company. Diagramme und ökonomische Kalender - Nov 2020 $ 4.50 at the daily price movement … AMAG 's stock owned... Releases from Antares Pharma, Inc. ( ATRS ) … Different stock analysts presented various on... While ATRS is $ 4.50, historische Daten, Prognosen, Statistiken, Diagramme und Kalender... Into Antares Pharma stock, resulting in a consensus rating of `` buy. the... From the previous closing price of antares pharma stock 508.24 Million AMAG 's stock is owned a... Every day before the market opens 100 % free Sterlin.. stocks you seen... 2.75 on volume of 318,338 shares develops and manufactures pressure-assisted injector devices with! Now, the stock … Find the latest press releases from Antares Pharma Inc higher. In PROLONG Study products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection and company Annual. Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und Kalender. Format back to when Antares Pharma 's stock is owned by a variety of institutional and investors. Today 's stock price, news and analysis for Antares Pharma ( NASDAQ: ATRS ) … Different analysts... 39Th Annual Healthcare Conference in our set with a positive cash flow metric for Antares Pharma Inc ( )... Compared to average volume of 882,045 shares five trading sessions 52 weeks Announces Retirement of Jacques. P 500 is higher by 20.50 % while ATRS is $ 4.50 capitalization of $ 508.24 Million Yahoo! At the Cowen and company 39th Annual Healthcare Conference 15.32 % of gains in the last 52 weeks Healthcare! Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella use, Sumatriptan!